Whole-body 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Demonstrating Multiple Rare Extracranial Metastases in a Treated Case of Glioblastoma.

التفاصيل البيبلوغرافية
العنوان:	Whole-body ¹⁸ F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Demonstrating Multiple Rare Extracranial Metastases in a Treated Case of Glioblastoma.
المؤلفون:	Kamaleshwaran KK; Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Coimbatore, Tamil Nadu, India., Ramkumar E; Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Coimbatore, Tamil Nadu, India., Raghunathan MS; Department of Radiotherapy, Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India.
المصدر:	Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India [Indian J Nucl Med] 2023 Jul-Sep; Vol. 38 (3), pp. 294-296. Date of Electronic Publication: 2023 Oct 10.
نوع المنشور:	Journal Article
اللغة:	English
بيانات الدورية:	Publisher: Medknow Country of Publication: India NLM ID: 8901274 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0972-3919 (Print) Linking ISSN: 09740244 NLM ISO Abbreviation: Indian J Nucl Med Subsets: PubMed not MEDLINE
أسماء مطبوعة:	Publication: 2008 : Mumbai : Medknow Original Publication: [Delhi] : Society of Nuclear Medicine, India
مستخلص:	Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the report of ¹⁸ F-fluorodeoxyglucose positron emission tomography/computed tomography ( ¹⁸ F-FDG PET/CT) imaging in evaluating ECM is limited, and the importance of whole-body FDG PET/CT imaging in GBM has not been well elucidated. We present here a case of GBM, post excision 12 years before, whole-body ¹⁸ F-FDG PET/CT showing no recurrence in the brain and ECM to multiple bones, right kidney, and pancreas. Competing Interests: There are no conflicts of interest. (Copyright: © 2023 Indian Journal of Nuclear Medicine.)
References:	Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):853. (PMID: 15776231) J Int Med Res. 2020 Jun;48(6):300060520930459. (PMID: 32552287) Tumori. 2008 Jan-Feb;94(1):40-51. (PMID: 18468334) Medicine (Baltimore). 2017 Jun;96(23):e7123. (PMID: 28591062) Clin Nucl Med. 2020 Mar;45(3):e162-e164. (PMID: 31876829) N Engl J Med. 2005 Mar 10;352(10):987-96. (PMID: 15758009) Rev Assoc Med Bras (1992). 2019 Mar;65(3):424-433. (PMID: 30994843) J Clin Oncol. 2014 Aug 1;32(22):e80-4. (PMID: 24567434)
فهرسة مساهمة:	Keywords: 18F-fluorodeoxyglucose positron emission tomography/computed tomography; extracranial metastases; glioblastoma; whole body
تواريخ الأحداث:	Date Created: 20231204 Latest Revision: 20231205
رمز التحديث:	20231215
مُعرف محوري في PubMed:	PMC10693363
DOI:	10.4103/ijnm.ijnm_167_22
PMID:	38046964
قاعدة البيانات:	MEDLINE

Find this article in full text from ProQuest

Full Text Finder

الوصف
تدمد:	0972-3919
DOI:	10.4103/ijnm.ijnm_167_22